Loon

Part of the NVIDIA Inception Program, AWS Activate, and Microsoft for Startups Founders Hub, Loon Inc. is pioneering Drugs Reimbursement Forecasting, Market Access Architecture, and Clinical Research Automation to de-risk the commercialization of novel health technologies. Using proprietary, patent-pending Cognitive Ensemble AI Systems™, Loon accelerates market access and optimizes Health Technology Assessment (HTA) processes. Loon's Agentic AI tools use scenario simulation and quantifiable risk assessment and mitigation to optimize value demonstration, maximize reimbursement potential, and reduce time-to-patient. Loon drastically reduces Health Economics and Outcomes Research (HEOR) timelines by providing scientifically validated AI evidence synthesis and generation services. The end-to-end AI evidence synthesis and market access forecasting services are HTA-grade, rigorous, transparent, and fully validated by experts. Loon helps sponsors, HTA bodies, clinical research organizations (CROs), policymakers, and market access consultancies: - streamline market access research and HEOR - predict committee decisions and timelines - optimize value demonstration in HTA value dossiers and payer submissions - maximize reimbursement potential - design reimbursement-friendly clinical trial protocols - adopt and execute decisions and policies based on up-to-date comprehensive evidence